Fungal strategies for overcoming host innate immune response.

A successful pathogen is one that is able to effectively survive and evade detection by the host innate immune defense. Fungal pathogens have adopted strategies which evade host defense and eventually cause disease in at-risk patients. Shielding of stimulatory surface recognition molecules, shedding of decoy components, induction of anti-inflammatory signals, complement evasion and resilient survival capacity are successful evasion mechanisms employed by fungal pathogens. Understanding these complex pathways of immune evasion can potentially contribute to development of novel therapeutic strategies against fungal infections.

[1]  S. Gordon,et al.  Immune recognition: A new receptor for β-glucans , 2001, Nature.

[2]  C. Janeway,et al.  Innate immune recognition. , 2002, Annual review of immunology.

[3]  M. Collins,et al.  Use of DBA/2N mice in models of systemic candidiasis and pulmonary and systemic aspergillosis , 1990, Infection and immunity.

[4]  A. Schaffner,et al.  Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus. Observations on these two lines of defense in vivo and in vitro with human and mouse phagocytes. , 1982, The Journal of clinical investigation.

[5]  Claire Collins,et al.  Immune sensing of Candida albicans requires cooperative recognition of mannans and glucans by lectin and Toll-like receptors. , 2006, The Journal of clinical investigation.

[6]  J. O'connor,et al.  Toll-like receptor-2 is essential in murine defenses against Candida albicans infections. , 2004, Microbes and infection.

[7]  K. Kim,et al.  Cryptococcal Yeast Cells Invade the Central Nervous System via Transcellular Penetration of the Blood-Brain Barrier , 2004, Infection and Immunity.

[8]  G. E. Dean,et al.  Regulation of the macrophage vacuolar ATPase and phagosome-lysosome fusion by Histoplasma capsulatum. , 1999, Journal of immunology.

[9]  I. Fraser,et al.  Pneumocystis carinii enhances soluble mannose receptor production by macrophages. , 2000, Microbes and infection.

[10]  F. Klis,et al.  Granulocytes govern the transcriptional response, morphology and proliferation of Candida albicans in human blood , 2005, Molecular microbiology.

[11]  P. R. Gardner,et al.  Inducible Defense Mechanism against Nitric Oxide in Candida albicans , 2004, Eukaryotic Cell.

[12]  Rongyu Liu,et al.  Interaction of airway epithelial cells (A549) with spores and mycelium of Aspergillus fumigatus. , 2005, The Journal of infection.

[13]  A. Mitchell,et al.  Function of Candida albicans Adhesin Hwp1 in Biofilm Formation , 2006, Eukaryotic Cell.

[14]  B. Beutler,et al.  Innate immune sensing and its roots: the story of endotoxin , 2003, Nature Reviews Immunology.

[15]  A. Blom,et al.  Immune evasion by acquisition of complement inhibitors: the mould Aspergillus binds both factor H and C4b binding protein. , 2008, Molecular immunology.

[16]  B. Kullberg,et al.  Combined effect of fluconazole and recombinant human interleukin-1 on systemic candidiasis in neutropenic mice , 1992, Antimicrobial Agents and Chemotherapy.

[17]  J. Latgé,et al.  Internalization of Aspergillus fumigatus conidia by epithelial and endothelial cells , 1997, Infection and immunity.

[18]  E. Maldonado,et al.  Pathogenesis of Histoplasma capsulatum. , 2001, Seminars in respiratory infections.

[19]  M. Netea,et al.  From the Th1/Th2 Paradigm towards a Toll-Like Receptor/T-Helper Bias , 2005, Antimicrobial Agents and Chemotherapy.

[20]  Alessandra Cambi,et al.  The C‐type lectin DC‐SIGN (CD209) is an antigen‐uptake receptor for Candida albicans on dendritic cells , 2003, European journal of immunology.

[21]  K. Kwon-Chung,et al.  The Developmentally Regulated alb1 Gene ofAspergillus fumigatus: Its Role in Modulation of Conidial Morphology and Virulence , 1998, Journal of bacteriology.

[22]  B. Klein,et al.  Virulence Factors of Medically Important Fungi , 1996 .

[23]  T. Meri,et al.  The Yeast Candida albicans Binds Complement Regulators Factor H and FHL-1 , 2002, Infection and Immunity.

[24]  S. Gordon,et al.  Dectin-1 escape by fungal dimorphism. , 2005, Trends in immunology.

[25]  W. Goldman,et al.  Histoplasma capsulatum fails to trigger release of superoxide from macrophages , 1987, Infection and immunity.

[26]  A. Blom,et al.  The Hyphal and Yeast Forms of Candida albicans Bind the Complement Regulator C4b-Binding Protein , 2004, Infection and Immunity.

[27]  J. Stringer,et al.  Genetics of Surface Antigen Expression inPneumocystis carinii , 2001, Infection and Immunity.

[28]  E. Balish,et al.  The role of phagocytic cells in resistance to disseminated candidiasis in granulocytopenic mice. , 1994, The Journal of infectious diseases.

[29]  P. Ricciardi-Castagnoli,et al.  Dendritic Cells Discriminate between Yeasts and Hyphae of the Fungus Candida albicans , 2000, The Journal of experimental medicine.

[30]  M. Dierich,et al.  The role of complement in invasive fungal infections , 2004, Mycoses.

[31]  R. Krzesicki,et al.  Damage to pseudohyphal forms of Candida albicans by neutrophils in the absence of serum in vitro. , 1978, The Journal of clinical investigation.

[32]  D. Golenbock,et al.  Toll-like Receptor (TLR) Signaling in Response toAspergillus fumigatus * , 2002, The Journal of Biological Chemistry.

[33]  T. Kozel,et al.  Activation of the complement system by pathogenic fungi , 1996, Clinical microbiology reviews.

[34]  A. Mitchell,et al.  Critical Role of Bcr1-Dependent Adhesins in C. albicans Biofilm Formation In Vitro and In Vivo , 2006, PLoS pathogens.

[35]  M. Netea,et al.  The role of toll-like receptor (TLR) 2 and TLR4 in the host defense against disseminated candidiasis. , 2002, The Journal of infectious diseases.

[36]  R. Furth,et al.  Contribution of granulocytes and monocytes to resistance against experimental disseminatedCandida albicans infection , 1988, European Journal of Clinical Microbiology and Infectious Diseases.

[37]  M. Netea,et al.  Role of TLR1 and TLR6 in the host defense against disseminated candidiasis. , 2008, FEMS immunology and medical microbiology.

[38]  T. Beccari,et al.  Downregulation by cryptococcal polysaccharide of tumor necrosis factor alpha and interleukin-1 beta secretion from human monocytes , 1995, Infection and immunity.

[39]  U. Reichard,et al.  A Parasitic Phase-Specific Adhesin of Coccidioides immitis Contributes to the Virulence of This Respiratory Fungal Pathogen , 2002, Infection and Immunity.

[40]  L. Jacobs,et al.  Aspergillus fumigatus evades immune recognition during germination through loss of toll-like receptor-4-mediated signal transduction. , 2003, The Journal of infectious diseases.

[41]  S. Filler,et al.  Fungal Invasion of Normally Non-Phagocytic Host Cells , 2006, PLoS pathogens.

[42]  D. Henderson,et al.  The Scientific Response to a Pandemic , 2006, PLoS pathogens.

[43]  P. Puccetti,et al.  Fungi, dendritic cells and receptors: a host perspective of fungal virulence. , 2002, Trends in microbiology.

[44]  D. Radzioch,et al.  Biological importance of the two Toll-like receptors, TLR2 and TLR4, in macrophage response to infection with Candida albicans. , 2005, FEMS immunology and medical microbiology.

[45]  T. Meshulam,et al.  Mechanisms and target sites of damage in killing of Candida albicans hyphae by human polymorphonuclear neutrophils. , 1997, The Journal of infectious diseases.

[46]  A. Casadevall,et al.  Cryptococcus neoformans survive and replicate in human microglia. , 1995, Laboratory investigation; a journal of technical methods and pathology.

[47]  D. Campa,et al.  Candida albicans isolates with different genomic backgrounds display a differential response to macrophage infection. , 2006, Microbes and infection.

[48]  W. Goldman,et al.  Histoplasma capsulatum α-(1,3)-glucan blocks innate immune recognition by the β-glucan receptor , 2007, Proceedings of the National Academy of Sciences.

[49]  Matt Post,et al.  Invasive fungal infections in allogeneic and autologous stem cell transplant recipients: a single‐center study of 166 transplanted patients , 2007, Transplant infectious disease : an official journal of the Transplantation Society.

[50]  A. Hartmann,et al.  The Opportunistic Human Pathogenic Fungus Aspergillus fumigatus Evades the Host Complement System , 2007, Infection and Immunity.

[51]  R. Clark,et al.  Damage to Aspergillus fumigatus and Rhizopus oryzae Hyphae by Oxidative and Nonoxidative Microbicidal Products of Human Neutrophils In Vitro , 1982, Infection and immunity.

[52]  M. Netea,et al.  An integrated model of the recognition of Candida albicans by the innate immune system , 2008, Nature Reviews Microbiology.

[53]  F. Bistoni,et al.  Purified capsular polysaccharide of Cryptococcus neoformans induces interleukin-10 secretion by human monocytes , 1996, Infection and immunity.

[54]  P. Sánchez-Corral,et al.  C4b-binding protein , 2002 .

[55]  A. Mantovani,et al.  The Contribution of the Toll-Like/IL-1 Receptor Superfamily to Innate and Adaptive Immunity to Fungal Pathogens In Vivo1 , 2004, The Journal of Immunology.

[56]  L. Romani.  Immunity to Candida albicans: Th1, Th2 cells and beyond. , 1999, Current opinion in microbiology.

[57]  H. Rubinstein,et al.  Immunosuppression, interleukin‐10 synthesis and apoptosis are induced in rats inoculated with Cryptococcus neoformans glucuronoxylomannan , 2004, Immunology.

[58]  A. Mitchell,et al.  Microbial biofilms: e pluribus unum , 2007, Current Biology.

[59]  Gerald R. Fink,et al.  Transcriptional Response of Candida albicans upon Internalization by Macrophages , 2004, Eukaryotic Cell.

[60]  F. Re,et al.  Toll-like Receptor 2 (TLR2) and TLR4 Differentially Activate Human Dendritic Cells* , 2001, The Journal of Biological Chemistry.

[61]  J. Kolls,et al.  Pneumocystis: immune recognition and evasion. , 2006, The international journal of biochemistry & cell biology.

[62]  A. Beauvais,et al.  Specific molecular features in the organization and biosynthesis of the cell wall of Aspergillus fumigatus. , 2005, Medical Mycology.

[63]  Gordon D. Brown,et al.  The role of the β‐glucan receptor Dectin‐1 in control of fungal infection , 2007 .

[64]  A. Casadevall,et al.  Melanization of Cryptococcus neoformans Affects Lung Inflammatory Responses during Cryptococcal Infection , 2005, Infection and Immunity.

[65]  S. Husain,et al.  Fungal infections in solid organ transplantation. , 2007, Medical mycology.

[66]  W. Gause,et al.  Th1- and Th2-cell commitment during infectious disease: asymmetry in divergent pathways. , 2001, Trends in immunology.

[67]  M. Moore,et al.  Aspergillus fumigatus conidia survive and germinate in acidic organelles of A549 epithelial cells , 2003, Journal of Cell Science.

[68]  L. Romani.  Immunity to fungal infections , 2011, Nature Reviews Immunology.

[69]  X. Shu,et al.  The pathobiology of Paracoccidioides brasiliensis. , 2002, Trends in microbiology.

[70]  D. Stevens.  Th1/Th2 in aspergillosis. , 2006, Medical mycology.

[71]  P. Schlesinger,et al.  Histoplasma capsulatum modulates the acidification of phagolysosomes , 1993, The Journal of experimental medicine.

[72]  M. Vidal,et al.  Mannose receptor contribution to Candida albicans phagocytosis by murine E‐clone J774 macrophages , 2003, Journal of leukocyte biology.

[73]  A. Casadevall,et al.  Phenotypic switching of Cryptococcus neoformans occurs in vivo and influences the outcome of infection. , 2001, The Journal of clinical investigation.

[74]  J. Heesemann,et al.  Phagocytosis of Aspergillus fumigatus conidia by murine macrophages involves recognition by the dectin‐1 beta‐glucan receptor and Toll‐like receptor 2 , 2007, Cellular microbiology.

[75]  M. Gardner,et al.  A Metalloproteinase of Coccidioides posadasii Contributes to Evasion of Host Detection , 2005, Infection and Immunity.

[76]  D. M. Lupan,et al.  Distinct characteristics of initiation of the classical and alternative complement pathways by Candida albicans , 1996, Infection and immunity.

[77]  J. O'connor,et al.  Toll-like receptor 4 defective mice carrying point or null mutations do not show increased susceptibility to Candida albicans in a model of hematogenously disseminated infection. , 2006, Medical mycology.

[78]  H. Smith,et al.  Resistance of virulent and attenuated strains of Candida albicans to intracellular killing by human and mouse phagocytes. , 1981, The Journal of infectious diseases.

[79]  M. Moore,et al.  Uptake of Aspergillus fumigatus Conidia by Phagocytic and Nonphagocytic Cells In Vitro: Quantitation Using Strains Expressing Green Fluorescent Protein , 2002, Infection and Immunity.

[80]  S. Gordon,et al.  Dectin-1 Mediates the Biological Effects of β-Glucans , 2003, The Journal of experimental medicine.

[81]  David L. Williams,et al.  Dectin‐1 promotes fungicidal activity of human neutrophils , 2007, European journal of immunology.

[82]  E. Nemoto,et al.  Saccharomyces cerevisiae‐ and Candida albicans‐Derived Mannan Induced Production of Tumor Necrosis Factor Alpha by Human Monocytes in a CD14‐ and Toll‐Like Receptor 4‐Dependent Manner , 2002, Microbiology and immunology.

[83]  S. Gordon,et al.  Rapid recruitment of late endosomes and lysosomes in mouse macrophages ingesting Candida albicans. , 1999, Journal of cell science.

[84]  M. Netea,et al.  Differential Cytokine Production and Toll-Like Receptor Signaling Pathways by Candida albicans Blastoconidia and Hyphae , 2005, Infection and Immunity.

[85]  S. Gordon,et al.  Dectin-1 is required for β-glucan recognition and control of fungal infection , 2007, Nature Immunology.

[86]  A. Aasen,et al.  Involvement of CD14 and Toll-Like Receptors in Activation of Human Monocytes by Aspergillus fumigatus Hyphae , 2001, Infection and Immunity.

[87]  T. Brandhorst,et al.  Exploiting Type 3 Complement Receptor for TNF-α Suppression, Immune Evasion, and Progressive Pulmonary Fungal Infection1 , 2004, The Journal of Immunology.

[88]  A. Casadevall,et al.  Persistent Cryptococcus neoformansPulmonary Infection in the Rat Is Associated with Intracellular Parasitism, Decreased Inducible Nitric Oxide Synthase Expression, and Altered Antibody Responsiveness to Cryptococcal Polysaccharide , 2000, Infection and Immunity.

[89]  L. J. Douglas,et al.  Candida biofilms and their role in infection. , 2003, Trends in microbiology.

[90]  Alistair J. P. Brown,et al.  Immune Recognition of Candida albicans β-glucan by Dectin-1 , 2007 .

[91]  S. Akira,et al.  Dectin-1 is required for host defense against Pneumocystis carinii but not against Candida albicans , 2007, Nature Immunology.

[92]  M. J. Cody,et al.  Signaling by Toll-Like Receptor 2 and 4 Agonists Results in Differential Gene Expression in Murine Macrophages , 2001, Infection and Immunity.

[93]  T. Brandhorst,et al.  The WI-1 Adhesin Blocks Phagocyte TNF-α Production, Imparting Pathogenicity on Blastomyces dermatitidis1 , 2001, The Journal of Immunology.

[94]  S. Akira,et al.  Pathogen Recognition and Innate Immunity , 2006, Cell.

[95]  B. Maresca,et al.  Host response and Histoplasma capsulatum/macrophage molecular interactions. , 2000, Medical mycology.

[96]  D. Underhill,et al.  Dectin‐1 mediates macrophage recognition of Candida albicans yeast but not filaments , 2005, The EMBO journal.

[97]  M. Netea,et al.  Toll-Like Receptor 2 Suppresses Immunity against Candida albicans through Induction of IL-10 and Regulatory T Cells , 2004, The Journal of Immunology.

[98]  A. Casadevall,et al.  Intracellular parasitism of macrophages by Cryptococcus neoformans. , 2001, Trends in microbiology.